Because CF is an autosomal recessive disorder, one could envision using PE-mediated recombination following a similar optimization process to what we describe here to install a functional copy of CFTR into the native site or into a genomic safe harbour locus to treat CF. The gene discussed is CFTR; the disease is cystic fibrosis.